Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift.
As healthcare AI opens new avenues to improve care quality without unduly increasing operational costs, the technology also expands potential exposure to civil and criminal liabilities. And that’s not only for providers but also payers and suppliers.
Data from nearly 9.9 million participants were included in the team’s final analysis. The group emphasized the important role governments can play in trying to reverse the world's reliance on these products.